Journal article
Perioperative management and outcomes in patients receiving low-dose rivaroxaban and/or aspirin: a subanalysis of the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial
Abstract
BACKGROUND: No study has investigated the perioperative management and clinical outcomes in patients who are receiving rivaroxaban 2.5 mg twice a day and acetylsalicylic acid (ASA) 81 to 100 mg daily.
OBJECTIVE: To assess perioperative management and outcomes in patients who are receiving low-dose rivaroxaban, 2.5 mg twice-daily, and low-dose ASA, 81 to 100 mg daily. To assess perioperative management and outcomes in patients who are receiving …
Authors
Douketis JD; Yi Q; Bhatt DL; Muehlhofer E; Wang MK; Connolly S; Yusuf S; Maggioni AP; Eikelboom JW
Journal
Journal of Thrombosis and Haemostasis, Vol. 22, No. 8, pp. 2227–2233
Publisher
Elsevier
Publication Date
August 2024
DOI
10.1016/j.jtha.2024.03.030
ISSN
1538-7933